Follow
F. Philipp Seib
F. Philipp Seib
Chair in Pharmaceutical Technology & Biopharmaceutics, Friedrich Schiller University Jena, Germany
Verified email at uni-jena.de - Homepage
Title
Cited by
Cited by
Year
The biomedical use of silk: past, present, future
C Holland, K Numata, J Rnjak‐Kovacina, FP Seib
Advanced healthcare materials 8 (1), 1800465, 2019
6042019
Functional immobilization of signaling proteins enables control of stem cell fate
K Alberti, RE Davey, K Onishi, S George, K Salchert, FP Seib, ...
Nature methods 5 (7), 645-650, 2008
2482008
Tightly anchored tissue-mimetic matrices as instructive stem cell microenvironments
MC Prewitz, FP Seib, M Von Bonin, J Friedrichs, A Stißel, C Niehage, ...
Nature methods 10 (8), 788-794, 2013
2342013
Comparison of the endocytic properties of linear and branched PEIs, and cationic PAMAM dendrimers in B16f10 melanoma cells
FP Seib, AT Jones, R Duncan
Journal of controlled release 117 (3), 291-300, 2007
2322007
pH‐dependent anticancer drug release from silk nanoparticles
FP Seib, GT Jones, J Rnjak‐Kovacina, Y Lin, DL Kaplan
Advanced healthcare materials 2 (12), 1606-1611, 2013
2262013
The growth and differentiation of mesenchymal stem and progenitor cells cultured on aligned collagen matrices
B Lanfer, FP Seib, U Freudenberg, D Stamov, T Bley, M Bornhäuser, ...
Biomaterials 30 (30), 5950-5958, 2009
1532009
Self‐assembling doxorubicin silk hydrogels for the focal treatment of primary breast cancer
FP Seib, EM Pritchard, DL Kaplan
Advanced functional materials 23 (1), 58-65, 2013
1512013
Multifunctional silk–heparin biomaterials for vascular tissue engineering applications
FP Seib, M Herklotz, KA Burke, MF Maitz, C Werner, DL Kaplan
Biomaterials 35 (1), 83-91, 2014
1302014
PEGylated silk nanoparticles for anticancer drug delivery
T Wongpinyochit, P Uhlmann, AJ Urquhart, FP Seib
Biomacromolecules 16 (11), 3712-3722, 2015
1202015
Doxorubicin-loaded silk films: drug-silk interactions and in vivo performance in human orthotopic breast cancer
FP Seib, DL Kaplan
Biomaterials 33 (33), 8442-8450, 2012
1162012
Matrix elasticity regulates the secretory profile of human bone marrow-derived multipotent mesenchymal stromal cells (MSCs)
FP Seib, M Prewitz, C Werner, M Bornhäuser
Biochemical and biophysical research communications 389 (4), 663-667, 2009
1022009
Impact of processing parameters on the haemocompatibility of Bombyx mori silk films
FP Seib, MF Maitz, X Hu, C Werner, DL Kaplan
Biomaterials 33 (4), 1017-1023, 2012
832012
Degradation behavior of silk nanoparticles—enzyme responsiveness
T Wongpinyochit, BF Johnston, FP Seib
ACS Biomaterials Science & Engineering 4 (3), 942-951, 2018
812018
Tissue engineering a surrogate niche for metastatic cancer cells
FP Seib, JE Berry, Y Shiozawa, RS Taichman, DL Kaplan
Biomaterials 51, 313-319, 2015
742015
Biocompatibility assessment of silk nanoparticles: hemocompatibility and internalization by human blood cells
MF Maitz, C Sperling, T Wongpinyochit, M Herklotz, C Werner, FP Seib
Nanomedicine: Nanotechnology, Biology and Medicine 13 (8), 2633-2642, 2017
732017
Surgery combined with controlled-release doxorubicin silk films as a treatment strategy in an orthotopic neuroblastoma mouse model
B Chiu, J Coburn, M Pilichowska, C Holcroft, FP Seib, A Charest, ...
British journal of cancer 111 (4), 708-715, 2014
702014
Stem cell implants for cancer therapy: TRAIL-expressing mesenchymal stem cells target cancer cells in situ
MR Reagan, FP Seib, DW McMillin, EK Sage, CS Mitsiades, SM Janes, ...
Journal of breast cancer 15 (3), 273, 2012
632012
Endogenous bone morphogenetic proteins in human bone marrow-derived multipotent mesenchymal stromal cells
FP Seib, M Franke, D Jing, C Werner, M Bornhäuser
European journal of cell biology 88 (5), 257-271, 2009
622009
Metabolic Reprogramming of Macrophages Exposed to Silk, Poly(lactic‐co‐glycolic acid), and Silica Nanoparticles
R Saborano, T Wongpinyochit, JD Totten, BF Johnston, FP Seib, IF Duarte
Advanced Healthcare Materials 6 (14), 1601240, 2017
582017
Establishment of subcellular fractionation techniques to monitor the intracellular fate of polymer therapeutics I. Differential centrifugation fractionation B16F10 cells and …
F Philipp Seib, AT Jones, R Duncan
Journal of drug targeting 14 (6), 375-390, 2006
582006
The system can't perform the operation now. Try again later.
Articles 1–20